Craneware (LSE:CRW) has warned that its financial results for the year ended 30 June 2026 are expected to come in below market forecasts, with revenue projected at between US$205 million and US$208 million and adjusted EBITDA of US$65 million to US$67 million. Both figures are broadly in line with the previous year. The company attributed the weaker-than-expected performance to delays in eligible 340B drug-related activity and the postponement of several large enterprise contracts into the 2027 financial year, despite maintaining strong customer retention, healthy demand and robust cash generation.
According to management, trading in the final months of the year was affected by slower conversion of identified 340B opportunities into recognised revenue after pharmaceutical manufacturers introduced and implemented tighter restrictions on the supply of certain medicines under the 340B programme. The board said the issue reflects timing rather than a deterioration in underlying demand, highlighting continued growth in demand for its technology-enabled operational transformation services. Craneware believes its increasing focus on helping healthcare providers realise, rather than simply identify, financial opportunities will strengthen its long-term strategic position in the evolving US healthcare sector.
Craneware’s outlook continues to be supported by strong financial fundamentals, including high gross margins and low leverage. However, weaker technical indicators, with the shares trading below major moving averages, create some near-term uncertainty. Valuation remains moderately supportive, with the stock trading on a price-to-earnings ratio of around 22.6 and offering a dividend yield of approximately 2.43%.
More about Craneware
Craneware is a healthcare technology company providing financial and operational performance solutions to hospitals and health systems, primarily across the United States. Its Trisus cloud platform combines data, revenue intelligence, margin intelligence and advanced analytics to help healthcare providers improve financial performance, operational efficiency and long-term sustainability.
The company combines healthcare expertise with AI-enabled workflows and a strategic partnership with Microsoft to develop advanced solutions, including the Trisus Chargemaster platform. By integrating technology with operational insight, Craneware aims to help healthcare organisations navigate increasingly complex financial and regulatory environments while improving long-term outcomes.
Leave a Reply